Skip to main content
. 2017 Aug 3;8(50):87151–87162. doi: 10.18632/oncotarget.19895

Figure 1.

Figure 1

Kaplan–Meier survival plots showed that no predictive role of BRCA1/2 mutations was found for recurrence-free survival (RFS) (A) and overall survival (OS) (B) in TNBC patients.